Published by Michele Maatouk on 15th November 2024
(Sharecast News) - Evotec surged on Friday after Halozyme Therapeutics confirmed it had submitted a non-binding proposal to buy the German biotech for €11.00 per share in cash, or about €2bn.
URL: http://www.digitallook.com/dl/news/story/34693906/...